GenSight attended 2nd Annual Cell & Gene Therapy Congress in London, UK. Anne Douar, Project Director, gave an oral presenation on “Translational development of GS030, an optogenetic therapy for retinal dystrophies combining a stimulating medical device” on Day 1, 5.50-6.20 pm.